Quality Investor

DuPont de Nemours, Inc.

Rank #413Startup

DD · NYSE · Basic Materials

DuPont de Nemours, Inc. (DD) — Rank #413 by gross profitability (GP/assets 0.11) · ROE -5.7% · Piotroski F-Score N/A.

As-of 2026-09-28 · CIK 0001666700 · all metrics point-in-time as of the filing date.

About

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.

Show more

It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc.

was incorporated in 2015 and is headquartered in Wilmington, Delaware.

Industry
Specialty Chemicals
Sector
Basic Materials
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31
Website
dupont.com

Financials

Stable

Direction over 5 fiscal years

  • Free cash flowdeteriorating
  • Gross marginstable
  • Gross profitabilitystable
  • Net cashstable
  • Operating marginn/a
  • Return on equitydeteriorating
  • Share count (dilution)deteriorating

Monitoring diagnostic of business direction — not a prediction of returns.

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end2025-12-31filed 2026-02-172024-12-31filed 2025-02-142023-12-31filed 2024-02-152022-12-31filed 2023-02-15
Income statement
EPS growth (YoY)-211.4%77.7%-92.0%—
Cash flow

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?